As of Nov 18, 2026, 0 of 2 active firms rate LSTA a Buy (2 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
LSTA EPS & revenue forecast
EPS · THIS QUARTER
$-0.74
Range $-0.74 – $-0.74 · 1 analysts · +35% YoY
Next period, 1 analysts expect Lisata Therapeutics Inc. to earn $-0.74 a share (range $-0.74 – $-0.74), versus $-0.55 a year earlier. Full-year consensus is $-1.09, growing to $-1.16 the year after.
REVENUE · THIS QUARTER
—
Range — – — · 1 analysts
Revenue is expected to reach — (range — – —). Full-year consensus is $0, rising to $0 next year.
Top analysts covering Lisata Therapeutics Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on LSTA.
#1
Joseph Pantginis
HC Wainwright & Co. · Rank #373
Neutral
No targeton LSTA
Overall win rate
34%
+ Follow
#2
KD
Kemp Dolliver
Brookline Capital Markets
Neutral
No targeton LSTA
Coverage
—
+ Follow
#3
KD
Kemp Dolliver
Brookline Capital
Neutral
No targeton LSTA
Coverage
—
+ Follow
LSTA stock forecast FAQ
Is LSTA stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 2 active firms as of Nov 18, 2026, 0 rate it Buy or Strong Buy, 2 rate it Neutral, and 0 rate it Sell or Strong Sell.
How many active Wall Street firms cover LSTA?+
2 active firms have a recognized rating on Lisata Therapeutics Inc. as of Nov 18, 2026.
Who is the most accurate analyst covering LSTA?+
Among analysts who currently cover LSTA, Joseph Pantginis of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #373). Their current call is Neutral.
What is Lisata Therapeutics Inc.'s projected EPS for next quarter?+
The consensus estimate is $-0.74 per share (range $-0.74 – $-0.74) across 1 analysts. Full-year EPS is projected at $-1.09, rising to $-1.16 the following year.
How much revenue is Lisata Therapeutics Inc. expected to report next quarter?+
Consensus revenue is — (range — – —). Full-year revenue is projected at $0, growing to $0 next year.
Have analysts been upgrading or downgrading LSTA lately?+
As of Nov 18, 2026, 0 of 2 active firms rate LSTA a Buy (2 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their LSTA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.